https://www.neurocyte.in/ankylosing-spondylitis-stem-cell-therapy/
Neurocyte carries out ankylosing spondylitis stem cell therapy, Stem Cell Therapy will help you to carry forward the cure of the disease. Stem Cell Therapy India.
Best stem cell therapy, Stem cell treatment center in Bangalore, Neurocyte Stem Cell Research Center is the best place to get stem cell treatment, stem cells
The global ankylosing spondylitis market size is expected to reach USD 8.45 billion by 2028 according to a new study by Polaris Market Research.
The report “Ankylosing Spondylitis Market Share, Size, Trends, Industry Analysis Report, By Drug (Cosentyx, Humira, Simponi, Remicade, Enbrel, Cimzia, Others); By Treatment Type (Painkillers and NSAIDs, DMARDs, Biological Therapies, Steroids, Physical Therapies, Surgery); By Regions; Segment Forecast, 2021 – 2028” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Ankylosing Spondylitis (AS), also known as Bechterew disease is the rare type of arthritis causing stiffness and intense pain in the individual’s spine, starting from lower back sacral bones.
AS could also spread to the neck region and damage to other adjoining joints.
Ankylosing spondylitis could cause inflammation and stiffness throughout the body, in few cases spine becomes weak, likely to be fractured easily, also interrupts the functioning of the cauda equine, group of nerves responsible for an individual’s bowel movements, reflexes, and sexual desires, around 40 percent of the patients suffering from AS are likely to suffer from eye-related problem uveitis, eye inflammation causing blurred vision, and individuals with AS in rare cases have large aorta.
Still, researchers are not being able to figure out what triggers ankylosing spondylitis, but there is a strong narrative that people with ankylosing spondylitis have a gene that codes protein called human leukocyte antigen B27 (HLA-B27).
